(Q46228867)

20 December 2017

title

Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma (English)

1 reference

20 December 2017

author name string

Tobias Klatte

1

1 reference

20 December 2017

Nils Kroeger

2

1 reference

20 December 2017

Edward N Rampersaud

3

1 reference

20 December 2017

Frédéric D Birkhäuser

4

1 reference

20 December 2017

Joshua E Logan

5

1 reference

20 December 2017

Geoffrey Sonn

6

1 reference

20 December 2017

Joseph Riss

7

1 reference

20 December 2017

P Nagesh Rao

8

1 reference

20 December 2017

Fairooz F Kabbinavar

9

1 reference

20 December 2017

Arie S Belldegrun

10

1 reference

20 December 2017

Allan J Pantuck

11

1 reference

20 December 2017

language of work or name

English

0 references

publication date

17 May 2012

1 reference

20 December 2017

published in

Cancer

1 reference

20 December 2017

volume

118

1 reference

20 December 2017

issue

23

1 reference

20 December 2017

page(s)

5777-5782

1 reference

20 December 2017

Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

The role of translation in neoplastic transformation from a pathologist's point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

The Myc oncoprotein as a therapeutic target for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

c-Myc and downstream targets in the pathogenesis and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Molecular biology of renal cortical tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Tumor biology and prognostic factors in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

8q Gain Is an Independent Predictor of Poor Survival in Diagnostic Needle Biopsies from Prostate Cancer Suspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

7 January 2021

Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

7 January 2021

Gain of chromosome 8q: a potential prognostic marker in resectable adenocarcinoma of the pancreas?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

7 January 2021

Prognostic significance of morphologic parameters in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

7 January 2021

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

7 January 2021

c-myc expression in renal carcinoma: correlation with clinical parameters

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

7 January 2021

The allelic loss of chromosome 3p25 with c‐myc gain is related to the development of clear‐cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27607

7 January 2021

Identifiers

DOI

10.1002/CNCR.27607

1 reference

20 December 2017

PubMed ID

22605478

1 reference

20 December 2017